XBiotech Inc. financial data

Symbol
XBIT on Nasdaq
Location
5217 Winnebago Lane, Austin, TX
State of incorporation
British Columbia, Canada
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.39K % -71.5%
Debt-to-equity 7.7 % +199%
Return On Equity -16 % -60.6%
Return On Assets -14.9 % -53%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 30.5M shares +0.15%
Common Stock, Shares, Outstanding 30.5M shares +0.14%
Entity Public Float 140M USD +5.77%
Common Stock, Value, Issued 272M USD +0.95%
Weighted Average Number of Shares Outstanding, Basic 30.5M shares +0.12%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 37.7M USD +16.6%
General and Administrative Expense 4.57M USD -8.77%
Operating Income (Loss) -42.3M USD -14.1%
Nonoperating Income (Expense) 9.56M USD -35.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -32.7M USD -47.5%
Income Tax Expense (Benefit) -163K USD -116%
Net Income (Loss) Attributable to Parent -32.7M USD -41.2%
Earnings Per Share, Basic -1.07 USD/shares -40.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 183M USD -9.43%
Accounts Receivable, after Allowance for Credit Loss, Current 730K USD -17.1%
Assets, Current 185M USD -9.48%
Deferred Income Tax Assets, Net 772K USD +20.2%
Property, Plant and Equipment, Net 24.8M USD -1.51%
Assets 210M USD -8.6%
Accounts Payable, Current 1.51M USD +2.59%
Employee-related Liabilities, Current 562K USD +14.9%
Accrued Liabilities, Current 4.49M USD +22.3%
Liabilities, Current 16M USD +202%
Accrued Income Taxes, Noncurrent 1.74M USD +5.95%
Deferred Income Tax Liabilities, Net 0 USD -100%
Liabilities 17.7M USD +156%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD -100%
Retained Earnings (Accumulated Deficit) -80.3M USD -68.5%
Stockholders' Equity Attributable to Parent 192M USD -13.7%
Liabilities and Equity 210M USD -8.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -7.2M USD -49.8%
Net Cash Provided by (Used in) Financing Activities 10.1M USD
Net Cash Provided by (Used in) Investing Activities -255K USD -4150%
Common Stock, Shares, Issued 30.4M shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.02M USD
Deferred Tax Assets, Valuation Allowance 17.6M USD +56.6%
Deferred Tax Assets, Gross 18.2M USD +40.1%
Depreciation 432K USD -2.48%
Payments to Acquire Property, Plant, and Equipment 255K USD +4150%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -33.1M USD -28.5%
Deferred Tax Assets, Operating Loss Carryforwards 1.29M USD
Unrecognized Tax Benefits 2.97M USD +3.81%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 628K USD -63.5%
Share-based Payment Arrangement, Expense 1.81M USD -49.8%